A recent clinical trial evaluating glutathione, vitamin C, and N-acetylcysteine reported no significant differences between treatment and placebo groups in either biochemical or behavioral measures, with the modest improvements observed being attributed to nonspecific effects related to clinical follow-up and study routine (Williams et al
We have written extensively about what BPC-157 actually does and the body protective compound clinical applications, and the short version is that the strongest evidence supports tendon and ligament repair, gut-lining integrity, and reduction of NSAID-related tissue damage
Additionally, the sodium content in SCW, crucial for hydration, parallels that of sports beverages (Shirreffs 2009
[92] The first patent for the therapeutic use of melatonin as a low-dose sleep aid was awarded to Richard Wurtman at the Massachusetts Institute of Technology in 1995
10.1021/acs.est.4c02132 Environ
References: Wu, G., Fang, Y